Boosted PIs in ARV-naïve patients: Virological suppression at 48 weeks

Boosted PIs

LPV/r QD is not approved in the EU. *Primary endpoint analysis. Data in figures are from different studies and cannot be compared directly. ITT, intent-to-treat; ITT-E, intent-to-treat exposed; M=F, missing = failure; NC=F, non-completer = failure; TLOVR, time to loss of virological response


Adapted from 1. Eron J et al. Lancet 2006;368:476–82; 2. Walmsley S et al. JAIDS 2009;50:367–74; 3. Molina J-M et al. Lancet 2008;372:646–55; 4. Gathe J et al. JAIDS 2009;50:474–81